Allergan drops Valeant-Ackman insider trading lawsuit

Allergan--now owned by Actavis ($ACT)--and its former hostile suitors, Valeant ($VRX) and Bill Ackman's Pershing Square, are putting the past behind them. Actavis has agreed to drop a lawsuit accusing the tandem of insider trading, and the takeover team is withdrawing its claims that Allergan made false statements about the Canadian pharma's business model, The Wall Street Journal reports. More (sub. req.)

Suggested Articles

The lawsuit is part of a years-long battle between the Cochrane Collaboration and Roche around Tamiflu's use against pandemic influenza.

Takeda forged a feasibility pact to see whether it could pair a plasma-based therapy with Elektrofi's microparticle delivery tech.

Sanofi's Dupixent is set to reach $12.5 billion in peak sales, Jefferies analysts wrote, affirming CEO Paul Hudson's focus on the immunology med.